BrainStorm Cell Therapeutics Inc. Study Positive for Spinal Cord Injuries

This article was originally published here

NEW YORK & PETACH TIKVAH, Israel–(BUSINESS WIRE)–BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI – News), a leading developer of adult stem cell technologies and therapeutics, has completed a preclinical study in collaboration with the W.M. Keck Center for Collaborative Neuroscience at Rutgers, The State University of New Jersey. The study conducted at the Keck Center was an effort to repair spinal…

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply